Isolation of 5-FU and CDDP-resistant mutants from a human gastric scirrhous cancer cell line, HSC-39

被引：0
|
作者：
Murase, Hiroko [1 ]
Okunaka, Mashiro [2 ]
Koike, Atsushi [1 ]
Tamaki, Rie [3 ]
Yanagihara, Kazuyoshi [2 ]
Amano, Fumio [1 ]
机构：
[1] Osaka Ubiv Pharm Sci, Lab Biodef & Regulat, Takatsuki, Osaka, Japan
[2] Expl Oncol & Clin Tria Ctr, Div Biomarker Discovery, Kashiwa, Chiba, Japan
[3] Kobe City Med Ctr Gen Hosp, Clin Trial Management Ctr, Kobe, Hyogo, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
Gastric cancer; Drug resistance;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3004
引用
收藏
页码：967 / 967
页数：1
相关论文
共 49 条
  • [31] Pazopanib and 5-FU/oxaliplatin as first-line treatment in advanced gastric cancer: PaFLO, a randomized phase II study from the AIO (Arbeitsgemeinschaft Internistische Onkologie)
    Thuss-Patience, Peter C.
    Al-Batran, Salah-Eddin
    Siveke, Jens T.
    Homann, Nils
    Malfertheiner, Peter
    Glaeser, Dietrich
    Stein, Alexander
    Tamm, Ingo
    Daum, Severin
    Potenberg, Jochem
    Florschuetz, Axel
    Vogel, Arndt
    Ridwelski, Karsten
    Ritgen, Matthias
    Geissler, Michael
    Schmalenberg, Harald
    Schlattmann, Peter
    Lorenz, Mario
    Breithaupt, Kirstin
    Pichlmeier, Uwe
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [32] Combined modalities of resistance in an oxaliplatin-resistant human gastric cancer cell line with enhanced sensitivity to 5-fluorouracil
    C-C Chen
    L-T Chen
    T-C Tsou
    W-Y Pan
    C-C Kuo
    J-F Liu
    S-C Yeh
    F-Y Tsai
    H-P Hsieh
    J-Y Chang
    [J]. British Journal of Cancer, 2007, 97 : 334 - 344
  • [33] Combined modalities of resistance in an oxaliplatin-resistant human gastric cancer cell line with enhanced sensitivity to 5-fluorouracil
    Chen, C-C
    Chen, L-T
    Tsou, T-C
    Pan, W-Y
    Kuo, C-C
    Liu, J-F
    Yeh, S-C
    Tsai, F-Y
    Hsieh, H-P
    Chang, J-Y
    [J]. BRITISH JOURNAL OF CANCER, 2007, 97 (03) : 334 - 344
  • [34] Induction of apoptosis in metastatic foci from human gastric cancer xenografts in nude mice and reduction of circulating tumor cells in blood by 5-FU and 1-hexylcarbamoyl-5-fluorouracil
    Nakanishi, H
    Abe, A
    Inada, K
    Tsukamoto, T
    Yasui, K
    Tatematsu, M
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1999, 125 (12) : 660 - 668
  • [35] Induction of apoptosis in metastatic foci from human gastric cancer xenografts in nude mice and reduction of circulating tumor cells in blood by 5-FU and 1-hexylcarbamoyl-5-fluorouracil
    Hayao Nakanishi
    Atsushi Abe
    Ken-ichi Inada
    Tetsuya Tsukamoto
    Kenzo Yasui
    Masae Tatematsu
    [J]. Journal of Cancer Research and Clinical Oncology, 1999, 125 : 660 - 668
  • [36] Multicenter phase 2 trial of weekly 5-FU plus l-LV regimen as salvage line chemotherapy for oral fluorouracil-resistant advanced gastric cancer (HGCSG15021
    Ueda, A.
    Muranaka, T.
    Kawamoto, Y.
    Sawada, K.
    Nakatsumi, H.
    Harada, K.
    Kobayashi, Y.
    Miyagishima, T.
    Hatanaka, K.
    Dazai, M.
    Kawahata, S.
    Sasaki, T.
    Sasaki, Y.
    Kato, S.
    Shinada, K.
    Tsuji, Y.
    Yuki, S.
    Sakamoto, N.
    Nishimoto, N.
    Sakata, Y.
    Komatsu, Y.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 48 - 48
  • [37] Activation of MAP kinases by 5-fluorouracil in a 5-fluorouracil-resistant variant human cell line derived from a KT breast cancer cell line
    Wu, YP
    Hiwasa, T
    Isogai, E
    Sonoda, T
    Kita, K
    Chen, Z
    Sugaya, S
    Yamamori, H
    Tanzawa, H
    Suzuki, N
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 13 (06) : 1241 - 1245
  • [38] Pembrolizumab (MK-3475) plus 5-fluorouracil (5-FU) and cisplatin for first-line treatment of advanced gastric cancer: Preliminary safety data from KEYNOTE-059.
    Fuchs, Charles S.
    Ohtsu, Atsushi
    Tabernero, Josep
    Van Cutsem, Eric
    Wang, Jiang Dian
    Lam, Baohoang
    Koshiji, Minori
    Bang, Yung-Jue
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [39] Multi-centered phase II trial of weekly 5-FU plus I-LV regimen as salvage line chemotherapy for oral fluorouracil resistant advanced gastric cancer (HGCSG1502)
    Sasaki, Y.
    Muranaka, T.
    Kawamoto, Y.
    Sawada, K.
    Nakatsumi, H.
    Harada, K.
    Miyagishima, T.
    Hatanaka, K.
    Dazai, M.
    Ueda, A.
    Sasaki, T.
    Shinada, K.
    Tsuji, Y.
    Yuki, S.
    Sakamoto, N.
    Nishimoto, N.
    Sakata, Y.
    Komatsu, Y.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [40] Reversal effect of 2′,4′-dihydroxy-6′-methoxy-3′,5′-dimethylchalcone on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU
    Huang, Hai-ya
    Niu, Jiang-long
    Zhao, Li-ming
    Lu, Yan-hua
    [J]. PHYTOMEDICINE, 2011, 18 (12) : 1086 - 1092
12345